WMU Biosciences Research & Commercialization Center — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
M3DOct 2023
Offers devices and services leveraging 3D CZT for real-time radiation imaging in the medical market.
HealthtechAnn Arbor, US
Michael Hopkins(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.